Basics Oric Pharmaceuticals, Inc. IPO Date: April 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $935.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.48 | 3.67% Avg Daily Range (30 D): $0.27 | 2.63% Avg Daily Range (90 D): $0.27 | 4.08% Institutional Daily Volume Avg Daily Volume: .37M Avg Daily Volume (30 D): .68M Avg Daily Volume (90 D): .89M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 71 Avg Trade Size (Sh.) (90 D): 86 Institutional Trades Total Inst.Trades: 752 Avg Inst. Trade: $1.46M Avg Inst. Trade (30 D): $1.57M Avg Inst. Trade (90 D): $1.25M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.72M Avg Closing Trade (30 D): $1.4M Avg Closing Trade (90 D): $1.26M Avg Closing Volume: 141.82K     News Jun 6, 2025 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Feb 7, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Jan 3, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants ... Source: Oric Pharmaceuticals, Inc. Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.87 $-.42 $-.51 Diluted EPS $-1.87 $-.42 $-.51 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -132.86M $ -30.02M $ -36.31M Operating Income / Loss $ -146.62M $ -32.72M $ -39.57M Cost of Revenue $ $ $ Net Cash Flow $ -7.03M $ -10.07M $ 15.18M PE Ratio